Filed: 2/6/2024ACC: 0001104659-24-011099
📋 What this filing means
WUXI APPTEC CO., LTD. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $38.57M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$38.57M
Total AUM (reported)
13.61M
Total Shares
Allocation by class
COM$30.25M78.4%
ADS$8.16M21.2%
SPONSORED ADS$151.4K0.4%
Portfolio Concentration
Top 3$38.27M99.2%
4–10$294.6K0.8%
Top 3 weight
99.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 13.61M
Sole
Full voting authority
13.61M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
LYELL IMMUNOPHARMA INC
SOLEShares8.18M
TypeSH
Market value$15.87M
41.15%
Sole
8.18M
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares1M
TypeSH
Market value$14.24M
36.92%
Sole
1M
Shared
0.00
None
0.00
ADAGENE INC
SOLEShares4.23M
TypeSH
Market value$8.16M
21.16%
Sole
4.23M
Shared
0.00
None
0.00
PURPLE BIOTECH LTD
SOLEShares194.14K
TypeSH
Market value$151.4K
0.39%
Sole
194.14K
Shared
0.00
None
0.00
CASTLE BIOSCIENCES INC
SOLEShares6.64K
TypeSH
Market value$143.2K
0.37%
Sole
6.64K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LYELL IMMUNOPHARMA INCSOLE | COM | 8.18M | SH | $15.87M 41.15% | 8.18M | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | COM | 1M | SH | $14.24M 36.92% | 1M | 0.00 | 0.00 |
ADAGENE INCSOLE | ADS | 4.23M | SH | $8.16M 21.16% | 4.23M | 0.00 | 0.00 |
PURPLE BIOTECH LTDSOLE | SPONSORED ADS | 194.14K | SH | $151.4K 0.39% | 194.14K | 0.00 | 0.00 |
CASTLE BIOSCIENCES INCSOLE | COM | 6.64K | SH | $143.2K 0.37% | 6.64K | 0.00 | 0.00 |